When is Wegovy's Patent Expected to Expire in Canada?
Wegovy's primary patent in Canada is currently set to expire on November 20, 2034 [1]. This patent covers the active pharmaceutical ingredient semaglutide [1].
What Does Patent Expiration Mean for Wegovy?
Once Wegovy's patents expire, it opens the door for other companies to produce and sell generic versions of the drug in Canada [2]. This typically leads to lower prices for consumers and increased market competition [2].
What Are Other Exclusivity Periods for Wegovy?
Beyond primary patents, other forms of market exclusivity can affect a drug's availability to generic manufacturers. These may include data protection periods, which prevent regulatory approval of generics even if patents have expired [3]. Information on specific data protection exclusivity for Wegovy in Canada is not readily available in the provided data.
Who Manufactures Wegovy?
Wegovy is manufactured by Novo Nordisk [4].
What is Wegovy Used For?
Wegovy is a prescription medication used for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition [4]. It is an injectable medication containing the active ingredient semaglutide, which belongs to a class of drugs known as GLP-1 receptor agonists [4].
How Does Wegovy Work?
Semaglutide mimics the action of the GLP-1 hormone, which plays a role in regulating appetite and food intake [4]. By targeting this pathway, Wegovy helps individuals feel fuller, reducing hunger and leading to a decrease in calorie consumption and subsequent weight loss [4].
What Are the Potential Side Effects of Wegovy?
Common side effects of Wegovy include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, and dizziness [4]. More serious side effects can occur, and patients should consult their healthcare provider about potential risks [4].
What Are the Concerns Around Wegovy's Availability and Cost?
Wegovy has faced significant demand since its approval, leading to supply challenges and high costs [5]. These factors have raised concerns for patients and healthcare providers regarding access to the medication [5]. The potential for lower-cost generic versions after patent expiry is a significant factor in addressing these affordability issues.
Where Can I Find More Information on Drug Patents?
For detailed information on drug patents and their expiration dates, DrugPatentWatch.com is a valuable resource [1].
Cited Sources
1. https://www.drugpatentwatch.com/
2. https://www.fda.gov/drugs/generic-drugs/what-generics-drugs
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078671/
4. https://www.wegovy.com/
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838877/